1408 related articles for article (PubMed ID: 25979160)
1. Quality of life and physical components linked to sarcopenia: The SarcoPhAge study.
Beaudart C; Reginster JY; Petermans J; Gillain S; Quabron A; Locquet M; Slomian J; Buckinx F; Bruyère O
Exp Gerontol; 2015 Sep; 69():103-10. PubMed ID: 25979160
[TBL] [Abstract][Full Text] [Related]
2. Prevalence of Sarcopenia in Community-Dwelling Chilean Elders According to an Adapted Version of the European Working Group on Sarcopenia in Older People (EWGSOP) Criteria.
Lera L; Albala C; Sánchez H; Angel B; Hormazabal MJ; Márquez C; Arroyo P
J Frailty Aging; 2017; 6(1):12-17. PubMed ID: 28244552
[TBL] [Abstract][Full Text] [Related]
3. Prevalence of Concomitant Bone and Muscle Wasting in Elderly Women from the SarcoPhAge Cohort: Preliminary Results.
Locquet M; Beaudart C; Reginster JY; Petermans J; Gillain S; Quabron A; Slomian J; Buckinx F; Bruyère O
J Frailty Aging; 2017; 6(1):18-23. PubMed ID: 28244553
[TBL] [Abstract][Full Text] [Related]
4. Bone health assessment in older people with or without muscle health impairment.
Locquet M; Beaudart C; Bruyère O; Kanis JA; Delandsheere L; Reginster JY
Osteoporos Int; 2018 May; 29(5):1057-1067. PubMed ID: 29445830
[TBL] [Abstract][Full Text] [Related]
5. Sarcopenia as a risk factor for falls in elderly individuals: results from the ilSIRENTE study.
Landi F; Liperoti R; Russo A; Giovannini S; Tosato M; Capoluongo E; Bernabei R; Onder G
Clin Nutr; 2012 Oct; 31(5):652-8. PubMed ID: 22414775
[TBL] [Abstract][Full Text] [Related]
6. Utility of four sarcopenia criteria for the prediction of falls-related hospitalization in older Australian women.
Sim M; Prince RL; Scott D; Daly RM; Duque G; Inderjeeth CA; Zhu K; Woodman RJ; Hodgson JM; Lewis JR
Osteoporos Int; 2019 Jan; 30(1):167-176. PubMed ID: 30456572
[TBL] [Abstract][Full Text] [Related]
7. Comparisons of sarcopenia defined by IWGS and EWGSOP criteria among older people: results from the I-Lan longitudinal aging study.
Lee WJ; Liu LK; Peng LN; Lin MH; Chen LK;
J Am Med Dir Assoc; 2013 Jul; 14(7):528.e1-7. PubMed ID: 23664768
[TBL] [Abstract][Full Text] [Related]
8. Sarcopenia and sarcopenic obesity among men aged 80 years and older in Beijing: prevalence and its association with functional performance.
Meng P; Hu YX; Fan L; Zhang Y; Zhang MX; Sun J; Liu Y; Li M; Yang Y; Wang LH; Zhang Y; Gao W; Han XQ; Chen LK
Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():29-35. PubMed ID: 24450558
[TBL] [Abstract][Full Text] [Related]
9. Predicting sarcopenia from functional measures among community-dwelling older adults.
Gray M; Glenn JM; Binns A
Age (Dordr); 2016 Feb; 38(1):22. PubMed ID: 26846414
[TBL] [Abstract][Full Text] [Related]
10. Consequences of applying the new EWGSOP2 guideline instead of the former EWGSOP guideline for sarcopenia case finding in older patients.
Reiss J; Iglseder B; Alzner R; Mayr-Pirker B; Pirich C; Kässmann H; Kreutzer M; Dovjak P; Reiter R
Age Ageing; 2019 Sep; 48(5):719-724. PubMed ID: 31112221
[TBL] [Abstract][Full Text] [Related]
11. Health-related quality of life and fall risk associated with age-related body composition changes; sarcopenia, obesity and sarcopenic obesity.
Öztürk ZA; Türkbeyler İH; Abiyev A; Kul S; Edizer B; Yakaryılmaz FD; Soylu G
Intern Med J; 2018 Aug; 48(8):973-981. PubMed ID: 29665258
[TBL] [Abstract][Full Text] [Related]
12. Instruments to assess sarcopenia and physical frailty in older people living in a community (care) setting: similarities and discrepancies.
Mijnarends DM; Schols JM; Meijers JM; Tan FE; Verlaan S; Luiking YC; Morley JE; Halfens RJ
J Am Med Dir Assoc; 2015 Apr; 16(4):301-8. PubMed ID: 25530211
[TBL] [Abstract][Full Text] [Related]
13. Physical function-derived cut-points for the diagnosis of sarcopenia and dynapenia from the Canadian longitudinal study on aging.
Tessier AJ; Wing SS; Rahme E; Morais JA; Chevalier S
J Cachexia Sarcopenia Muscle; 2019 Oct; 10(5):985-999. PubMed ID: 31307126
[TBL] [Abstract][Full Text] [Related]
14. Strength measures are better than muscle mass measures in predicting health-related outcomes in older people: time to abandon the term sarcopenia?
Menant JC; Weber F; Lo J; Sturnieks DL; Close JC; Sachdev PS; Brodaty H; Lord SR
Osteoporos Int; 2017 Jan; 28(1):59-70. PubMed ID: 27394415
[TBL] [Abstract][Full Text] [Related]
15. Case finding for sarcopenia in geriatric inpatients: performance of bioimpedance analysis in comparison to dual X-ray absorptiometry.
Reiss J; Iglseder B; Kreutzer M; Weilbuchner I; Treschnitzer W; Kässmann H; Pirich C; Reiter R
BMC Geriatr; 2016 Feb; 16():52. PubMed ID: 26928275
[TBL] [Abstract][Full Text] [Related]
16. Cut-off points to identify sarcopenia according to European Working Group on Sarcopenia in Older People (EWGSOP) definition.
Bahat G; Tufan A; Tufan F; Kilic C; Akpinar TS; Kose M; Erten N; Karan MA; Cruz-Jentoft AJ
Clin Nutr; 2016 Dec; 35(6):1557-1563. PubMed ID: 26922142
[TBL] [Abstract][Full Text] [Related]
17. Using two different algorithms to determine the prevalence of sarcopenia.
Yoshida D; Suzuki T; Shimada H; Park H; Makizako H; Doi T; Anan Y; Tsutsumimoto K; Uemura K; Ito T; Lee S
Geriatr Gerontol Int; 2014 Feb; 14 Suppl 1():46-51. PubMed ID: 24450560
[TBL] [Abstract][Full Text] [Related]
18. The prevalence of sarcopenia in very old individuals according to the European consensus definition: insights from the BELFRAIL study.
Legrand D; Vaes B; Matheï C; Swine C; Degryse JM
Age Ageing; 2013 Nov; 42(6):727-34. PubMed ID: 24014657
[TBL] [Abstract][Full Text] [Related]
19. Prevalence of sarcopenia: the impact of different diagnostic cut-off limits.
Beaudart C; Reginster JY; Slomian J; Buckinx F; Locquet M; Bruyère O
J Musculoskelet Neuronal Interact; 2014 Dec; 14(4):425-31. PubMed ID: 25524968
[TBL] [Abstract][Full Text] [Related]
20. Sarcopenia prevalence and factors associated with sarcopenia in older people living in a nursing home in Ankara Turkey.
Yalcin A; Aras S; Atmis V; Cengiz OK; Varli M; Cinar E; Atli T
Geriatr Gerontol Int; 2016 Aug; 16(8):903-10. PubMed ID: 26245888
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
